β2-Adrenergic receptor activation on donor cells ameliorates acute GvHD
PublisherThe American Society for Clinical Investigation
MetadataShow full item record
AbstractAcute graft versus host disease (aGvHD) remains a major impediment to successful allogeneic hematopoietic cell transplantation (allo-HCT). To solve this problem, a greater knowledge of factors that regulate the differentiation of donor T cells toward cytotoxic cells or Tregs is necessary. We report that the β2-adrenergic receptor (β2-AR) is critical for regulating this differentiation and that its manipulation can control aGvHD without impairing the graft-versus-tumor (GvT) effect. Donor T cell β2-AR expression and signaling is associated with decreased aGvHD when compared with recipients of β2-AR-/- donor T cells. We determined that β2-AR activation skewed CD4+ T cell differentiation in vitro and in vivo toward Tregs rather than the T helper 1 (Th1) phenotype. Treatment of allo-HCT recipients with a selective β2-agonist (bambuterol) ameliorated aGvHD severity. This was associated with increased Tregs, decreased cytotoxic T cells, and increased donor BM-derived myeloid-derived suppressor cells (MDSCs) in allogeneic and humanized xenogeneic aGvHD models. β2-AR signaling resulted in increased Treg generation through glycogen synthase kinase-3 activation. Bambuterol preserved the GvT effect by inducing NKG2D+ effector cells and central memory T cells. These data reveal how β-AR signaling can be targeted to ameliorate GvHD severity while preserving GvT effect.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85086747266&doi=10.1172%2fjci.insight.137788&partnerID=40&md5=d38e356034ab5112f1ac056ec4e07d0d; http://hdl.handle.net/10713/13182
- HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
- Authors: Yao Y, Wang L, Zhou J, Zhang X
- Issue date: 2017 Feb 10
- Notch pathway plays a novel and critical role in regulating responses of T and antigen-presenting cells in aGVHD.
- Authors: Luo X, Xu L, Li Y, Tan H
- Issue date: 2017 Apr
- [The role of CD4+ CD25+ T cell and FOXP3 in hsot acute graft rejection].
- Authors: Liu YJ, Wu DP, Li CX, He J, Qiu QC, Zhang XG
- Issue date: 2006 Oct
- Myeloid-derived suppressor cells therapy enhance immunoregulatory properties in acute graft versus host disease with combination of regulatory T cells.
- Authors: Park MJ, Baek JA, Kim SY, Jung KA, Choi JW, Park SH, Kwok SK, Cho ML
- Issue date: 2020 Dec 14